Industry

Cases include patients who failed prior treatment attempts for in-stent restenosis and native vessel obstructions REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana® Thrombectomy Catheter System. The cases were performed across the company’s limited US … [Read more…]

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position and the revenues from its Named Patient Early Access Program as of March 31, 2026. Cash position as of … [Read more…]

New portfolio embeds AI across core FM workflows to move facilities teams from reactive overload to strategic impact GREENVILLE, S.C.–(BUSINESS WIRE)–ServiceChannel, the leading platform for the procurement and delivery of facilities services, today announced the launch of ServiceChannel AI, the AI operating system for facilities management that embeds intelligence directly where facilities work gets done. … [Read more…]

ALZ-507 Designed as Well-Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 Corrector ALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and Pharmacokinetic Profile that Supports Once-Daily Dosing ALZ-507 Broadens Alzheon’s Proprietary Precision Medicine Therapeutic Pipeline Targeting Disease Modification in Alzheimer’s Disease FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ALZ801—Alzheon, Inc., a clinical-stage biopharmaceutical company … [Read more…]

~Approximately 100 times faster, will accelerate solutions for drug discovery, finance, and other complex problems~ KAWASAKI, Japan–(BUSINESS WIRE)–#SBM–Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprietary quantum‑inspired combinatorial optimization computer. The new algorithm significantly improves the probability of obtaining an optimal solution or a … [Read more…]

– Accelerating preclinical development toward IND submission in H1 next year, positioning ABN202 as a potential game changer in oncology SEOUL, South Korea–(BUSINESS WIRE)–#AACR2026—ABION (KOSDAQ, 203400), a precision oncology therapeutics developer, announced that its next-generation immuno-oncology candidate, ABN202, demonstrated a superior anti-cancer mechanism compared with TROP2-targeting antibody-drug conjugates (ADCs) in preclinical studies. The findings will … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#GlobalPublicHealth–On World Health Day, observed annually on April 7, AIDS Healthcare Foundation (AHF) calls for global solidarity to fight infectious diseases and urges key global leaders—particularly in Europe—to help deliver it by advancing an equitable World Health Organization Pandemic Agreement, including a binding and enforceable Pathogen Access and Benefit Sharing (PABS) Annex. Without … [Read more…]

NEWTON, Mass.–(BUSINESS WIRE)–Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq closes on Monday, May 4, 2026. On Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew … [Read more…]

Report outlines advancements in whole-person health, community partnerships, and environmental stewardship LOUISVILLE, Ky.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: HUMANA RELEASES 2025 IMPACT REPORT, HIGHLIGHTING PROGRESS TOWARDS SIMPLER, MORE AFFORDABLE CARE FOR PEOPLE AND COMMUNITIES Report outlines advancements in whole-person health, community partnerships, and … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–3Strands Global Foundation (3SGF) and Anthem Blue Cross and Blue Shield in Virginia (Anthem) announced a strategic partnership to provide comprehensive “whole health” support to members in foster care, their guardians, caregivers, and Care Managers throughout the Commonwealth of Virginia. This enhances the Virginia Foster Care Specialty Plan (FCSP), administered by Anthem Health … [Read more…]